Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emilija Mitrikeska"'
Autor:
Ulka Vaishampayan, Darshana Patil, Wahida Rahman, Stephanie Patterson, Emilija Mitrikeska, Joe Dib
Publikováno v:
Cancer Research. 83:OT3-18
Introduction The Standard of Care for early detection of breast cancer in asymptomatic women is screening mammography, which has limitations such as radiation exposure and lower sensitivity to detect cancer in women with high breast density or invasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9752508275386e8f20ec04aff073e766
https://doi.org/10.1158/1538-7445.sabcs22-ot3-18-02
https://doi.org/10.1158/1538-7445.sabcs22-ot3-18-02
Autor:
Moshe Talpaz, Nicholas J. Donato, Shaomeng Wang, Jessica Mercer, Emilija Mitrikeska, Diane Giannola, Luke F. Peterson, Miao Chia Lo, Craig N. Johnson, Yihong Liu
Publikováno v:
Leukemialymphoma. 58(9)
Chronic myeloid leukemia (CML) is characterized by the chromosomal translocation 9;22, known as the Philadelphia chromosome (Ph), which produces the BCR-ABL fusion tyrosine kinase. Although well-managed by BCR-ABL tyrosine kinase inhibitors (TKIs), t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590c2c4b3287f508fb784ad9db210faa
https://pubmed.ncbi.nlm.nih.gov/28084835
https://pubmed.ncbi.nlm.nih.gov/28084835
Autor:
Y Lui, Emilija Mitrikeska, Shaomeng Wang, Sami N. Malek, Hanshi Sun, Moshe Talpaz, Diane Giannola, Luke F. Peterson, Nicholas J. Donato, Dale L. Bixby
Publikováno v:
Leukemia. 25(5)
Philadelphia chromosome positive chronic myeloid leukemia has a progressive course starting in a benign phase and terminating in a blastic phase. In this study, we show that human homolog double minute 2 (HDM2) inhibition, with MI-219-a novel compoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72b74d1c45320ca735e6ba1d8a4a17ba
https://pubmed.ncbi.nlm.nih.gov/21350558
https://pubmed.ncbi.nlm.nih.gov/21350558
Autor:
Luke F. Peterson, Moshe Talpaz, Shaomeng Wang, Emilija Mitrikeska, Nicholas J. Donato, Craig N. Johnson, Miao Chia Lo, Diane Gianolla, Jessica Mercer, Yihong Lui
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:S215
Chronic myelogenous leukemia (CML) is a hematological disease resulting from generation of BCR/ABL oncogene. Resveratrol is an important phytoalexin which is contained in many plants and it has cytotoxic effects in various cancer types. Gene promoter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dcfbc2e0d483159ba5d060e57ee6569
https://doi.org/10.1016/j.clml.2015.04.084
https://doi.org/10.1016/j.clml.2015.04.084
Publikováno v:
Blood. 116:3433-3433
Abstract 3433 The development of Ph− clones with new cytogenetic abnormalities has been reported among CML patients with complete cytogenetic remission (CCR) following diverse therapies such as Interferon and Imatinib (Gleevec). The etiologies for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2ea8ca49bad78d86ff71fa3b38c1d3
https://doi.org/10.1182/blood.v116.21.3433.3433
https://doi.org/10.1182/blood.v116.21.3433.3433